EL
ENDRA Life Sciences Inc
🇺🇸XNAS.NDRAUnited StatesHealthcare
$5.74USDdown -0.13 (-2.21%)Pre-marketDelayed1:28 PM
Price$5.74-0.13 (-2.21%)
Profile
- Healthcare
- Diagnostics & Research
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US29273B1044
- CUSIP
- 29273B203
Company
- Employees
- 9
- Headquarters
- Ann Arbor, United States
- Website
- https://endrainc.com
- CEO
- Mr. Alexander Y. Tokman
Market
- Shares outstanding
- 1.5M
- Market cap
- $8.61M
Highlights
- Market cap
- $8.37M
- EPS LTM
- -$3.94calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.46calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$5.92M+32.5%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$7.84M-40.1%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.